CA2650813A1 - New long-acting drug combinations for the treatment of respiratory diseases - Google Patents

New long-acting drug combinations for the treatment of respiratory diseases Download PDF

Info

Publication number
CA2650813A1
CA2650813A1 CA002650813A CA2650813A CA2650813A1 CA 2650813 A1 CA2650813 A1 CA 2650813A1 CA 002650813 A CA002650813 A CA 002650813A CA 2650813 A CA2650813 A CA 2650813A CA 2650813 A1 CA2650813 A1 CA 2650813A1
Authority
CA
Canada
Prior art keywords
acid
pharmaceutical composition
composition according
denotes
propellant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002650813A
Other languages
English (en)
French (fr)
Inventor
Ingo Konetzki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International Gmbh
Ingo Konetzki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International Gmbh, Ingo Konetzki filed Critical Boehringer Ingelheim International Gmbh
Publication of CA2650813A1 publication Critical patent/CA2650813A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002650813A 2006-05-24 2007-05-15 New long-acting drug combinations for the treatment of respiratory diseases Abandoned CA2650813A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06114540.5 2006-05-24
EP06114540 2006-05-24
PCT/EP2007/054700 WO2007135024A1 (en) 2006-05-24 2007-05-15 New long-acting drug combinations for the treatment of respiratory diseases

Publications (1)

Publication Number Publication Date
CA2650813A1 true CA2650813A1 (en) 2007-11-29

Family

ID=37832901

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002650813A Abandoned CA2650813A1 (en) 2006-05-24 2007-05-15 New long-acting drug combinations for the treatment of respiratory diseases

Country Status (4)

Country Link
EP (1) EP2029127A1 (ja)
JP (1) JP2010526763A (ja)
CA (1) CA2650813A1 (ja)
WO (1) WO2007135024A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2739352T3 (es) * 2009-02-26 2020-01-30 Glaxo Group Ltd Formulaciones farmacéuticas que comprenden 4-{(1R)-2-[(6-{2-[(2,6-diclorobencil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2-(hidroximetil)fenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452179A1 (en) * 2003-02-27 2004-09-01 CHIESI FARMACEUTICI S.p.A. Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid
DE10323966A1 (de) * 2003-05-27 2004-12-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
CA2533791C (en) * 2003-07-28 2012-05-22 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising betamimetics and an anticholinergic agent
US20050025718A1 (en) * 2003-07-31 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
US20060034776A1 (en) * 2004-08-10 2006-02-16 Boehringer Ingelheim International Gmbh Inhalable medicaments containing a new anticholinergic, corticosteroids, and betamimetics

Also Published As

Publication number Publication date
WO2007135024A1 (en) 2007-11-29
EP2029127A1 (en) 2009-03-04
JP2010526763A (ja) 2010-08-05

Similar Documents

Publication Publication Date Title
US7244742B2 (en) Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
US20070128125A1 (en) Pharmaceutical Compositions Based on Tiotropium Salts and Salts of Salmeterol
US20060057074A1 (en) Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
JP5081158B2 (ja) 呼吸器系疾患治療用の新規な医薬組成物
US20090088408A1 (en) Pharmaceutical compositions on anticholinergics, corticosteroids and betamimetics
US20040010003A1 (en) Medicaments comprising betamimetics and a novel anticholinergic
US7332175B2 (en) Long-acting drug combinations for the treatment of respiratory complaints
US20060069073A1 (en) Medicaments for inhalation comprising steroids and an anticholinergic
US20060239935A1 (en) Compositions for inhalation
IL155718A (en) Pharmaceutical preparations based on tiotropium salts and salmetrol salts
NZ536337A (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
CA2560131A1 (en) Compounds for treating proliferative processes
US20020122773A1 (en) Pharmaceutical compositions based on anticholinergics and dopamine agonists
US20110135580A1 (en) Novel Medicament Combinations for the Treatment of Respiratory Diseases
US20060239908A1 (en) Compositions for inhalation
CA2527178A1 (en) New long-acting drug combinations for the treatment of respiratory complaints
CA2650813A1 (en) New long-acting drug combinations for the treatment of respiratory diseases
EP1959942A1 (en) Method for the treatment of dyspnea comprising combined administration of tiotropium salts and salts of salmeterol
CA2430592C (en) New pharmaceutical compositions based on anticholinergics and dopamine agonists
US20100234411A1 (en) New Combination for the Treatment of Respiratory Diseases
WO2005023269A1 (en) Medicament compositions comprising a heterocyclic compound and an anticholinergic

Legal Events

Date Code Title Description
FZDE Dead